Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Molecular Weight:
Approximately 145.53 kDa
Purity:
99.50%
CAS Number:
[180288-69-1]
Target:
ADC Antibody|||EGFR
T9912
* VAT and and shipping costs not included. Errors and price changes excepted